MSB 7.69% $1.19 mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-67

  1. 136 Posts.
    lightbulb Created with Sketch. 25
    We need more exposure. The 180 trial result announcement is not even on seeking alpha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.